P163 Glucocerebrosidase deficiency and dopaminergic cell death: Relevance to Parkinson disease

Basal Ganglia ◽  
2011 ◽  
Vol 1 (1) ◽  
pp. 40
Author(s):  
D. Alvarez-Fischer ◽  
C. Noelker ◽  
L. Lu ◽  
A. Sturn ◽  
R. Roscher ◽  
...  
2014 ◽  
Vol 11 (1) ◽  
pp. 86 ◽  
Author(s):  
Carmen Noelker ◽  
Lydie Morel ◽  
Anke Osterloh ◽  
Daniel Alvarez-Fischer ◽  
Thomas Lescot ◽  
...  

Neuron ◽  
2016 ◽  
Vol 90 (4) ◽  
pp. 675-691 ◽  
Author(s):  
Patrick P. Michel ◽  
Etienne C. Hirsch ◽  
Stéphane Hunot

Author(s):  
Jamila Zaiter ◽  
Achraf Hibot ◽  
Abderrafia Hafid ◽  
Mostafa Khouili ◽  
Claudia M.B. Neves ◽  
...  

Author(s):  
Irene García-Domínguez ◽  
Karolina Veselá ◽  
Juan García-Revilla ◽  
Alejandro Carrillo-Jiménez ◽  
María Angustias Roca-Ceballos ◽  
...  

2021 ◽  
pp. 576-582
Author(s):  
Sarah M. Tisel ◽  
Bryan T. Klassen

Parkinson disease (PD) is the classic hypokinetic movement disorder and one of the most common and widely recognized neurodegenerative conditions. PD is distinct from parkinsonism, a term that refers to a syndrome of rest tremor, bradykinesia, rigidity, and postural instability. The mechanism behind the progressive degeneration and cell death that result in PD is not precisely understood. Substantia nigra depigmentation occurs on a macroscopic level and loss of dopaminergic neurons and gliosis on a microscopic level.


2019 ◽  
Vol 35 (4) ◽  
pp. 918-930 ◽  
Author(s):  
Ana-Luisa Gil-Martínez ◽  
Cristina Estrada ◽  
Lorena Cuenca ◽  
Juan-Antonio Cano ◽  
Manuel Valiente ◽  
...  

2004 ◽  
Vol 89 (6) ◽  
pp. 1490-1497 ◽  
Author(s):  
Youichirou Higashi ◽  
Masato Asanuma ◽  
Ikuko Miyazaki ◽  
Nobutaka Hattori ◽  
Yoshikuni Mizuno ◽  
...  
Keyword(s):  

Mitochondrion ◽  
2007 ◽  
Vol 7 (6) ◽  
pp. 411
Author(s):  
M. Marella ◽  
B.B. Seo ◽  
A. Matsuno-Yagi ◽  
T. Yagi

Sign in / Sign up

Export Citation Format

Share Document